Literature DB >> 17075722

Exploration of the emergence of the Victoria lineage of influenza B virus.

J-M Chen1, Y-J Guo, K-Y Wu, J-F Guo, M Wang, J Dong, Y Zhang, Z Li, Y-L Shu.   

Abstract

The Victoria lineage represented by B/Victoria/2/87 is one of the two major distinctive haemagglutinin (HA) lineages of influenza B virus, and its recent re-emergence has aroused great concerns. However, it remains unknown when, where, and how this HA lineage emerged in the world. In this study, the HA1 domain of the HA gene of fourteen influenza B viruses isolated in China in 1972-1984 was sequenced. The sequences were phylogenetically analyzed with the HA1 sequences of 41 other important influenza B isolates. The results unveiled some earlier footprints of the Victoria lineage in China, and the epidemic history of the Victoria lineage could be traced back from the year 1985 to 1975. Moreover, phylogenetic analysis, the history of China, and the epidemiology of influenza B virus indicated that the Victoria lineage possibly emerged in China in the 1970s through gradual evolution from a minor lineage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075722     DOI: 10.1007/s00705-006-0852-6

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  Quadrivalent influenza vaccine in the United States.

Authors:  Manika Suryadevara; Joseph B Domachowske
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

Review 2.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

3.  Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage.

Authors:  Carolien E van de Sandt; YingYing Dou; Stella E Vogelzang-van Trierum; Kim B Westgeest; Mark R Pronk; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan; Marine L B Hillaire
Journal:  J Gen Virol       Date:  2015-04-21       Impact factor: 3.891

4.  The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus.

Authors:  Fengyun Ni; Innocent Nnadi Mbawuike; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

5.  Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.

Authors:  Rory D de Vries; Nella J Nieuwkoop; Fiona R M van der Klis; Marion P G Koopmans; Florian Krammer; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

6.  Structural basis for the divergent evolution of influenza B virus hemagglutinin.

Authors:  Fengyun Ni; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2013-08-27       Impact factor: 3.616

7.  The impact of matching vaccine strains and post-SARS public health efforts on reducing influenza-associated mortality among the elderly.

Authors:  Ta-Chien Chan; Chuhsing Kate Hsiao; Chang-Chun Lee; Po-Huang Chiang; Chuan-Liang Kao; Chung-Ming Liu; Chwan-Chuen King
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

8.  Diversifying selective pressure on influenza B virus hemagglutinin.

Authors:  Jun Shen; Brian D Kirk; Jianpeng Ma; Qinghua Wang
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

9.  The coming era of quadrivalent human influenza vaccines: who will benefit?

Authors:  Ian G Barr; Lauren L Jelley
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

10.  Virological investigation of four outbreaks of influenza B reassortants in the northern region of Taiwan from October 2006 to February 2007.

Authors:  Yuan-Ming Lee; Sheng-Fan Wang; Cheng-Ming Lee; Kuan-Hsuan Chen; Yu-Jiun Chan; Wu-Tse Liu; Yi-Ming Arthur Chen
Journal:  BMC Res Notes       Date:  2009-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.